drugset / Trial / NCT02873702

Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis

NCT02873702

Phase 3 Terminated 37 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy of dexlansoprazole compared to lansoprazole in healing erosive esophagitis (EE) in Chinese participants.

Timeline

Start
2016-12-21
Primary completion
2017-10-16
Completion
2017-11-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexlansoprazole Other / unclassified 30 mg Oral
Subject Dexlansoprazole Other / unclassified 60 mg Oral
Subject Lansoprazole Other / unclassified 30 mg Oral

Indications